Informing Patients About Their Surgery's Environmental Impact: an Effective Pathway to Sustainable Healthcare?

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Amsterdam

About this trial

The healthcare sector contributes significantly to climate change. Reducing the number of patients receiving resource-intensive procedures such as surgery can lower carbon emissions, particularly when two treatments with comparable clinical outcomes are available. Nevertheless, the impact of incorporating environmental considerations into patients' decision-making processes remains underexplored. The investigators examine how including information about the environmental impact of treatment options in a gallstone decision aid affects patients' real-life choice between surgery and the more sustainable alternative of conservative treatment. Moreover, the investigators examine whether factors such as severity of symptoms moderate the relation between sustainability information and patients' treatment choice. An exploratory vignette study informed the hypotheses that will be tested among actual patients with gallstones making actual treatment decisions. The results of this ecologically valid study have implications for both clinical practice and healthcare policy by offering insight into the effectiveness of pathways to include patients in the transition towards sustainable healthcare.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who were referred to three participating hospitals located across the Netherlands

Patients who received PatientPlus' gallstone decision aid in preparation for their surgical consultation

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sustainability added to decision aid

    Behavioral

    The intervention decision aid includes a page with information about the environmental impact of surgical removal of the gallbladder, and a control condition, which includes no such information. Besides information about the environmental impact of gallbladder surgery, the intervention and control conditions will be identical. At the end of the decision aid patients will be debriefed in general phrasing (i.e., the aim of this study was to examine which factors affect treatment choice) to prevent influencing the actual decision. Approximately three months after patients received the decision aid, patients will receive an invitation via the PatientPlus portal to complete a survey in which the investigators inquire about their final treatment decision (first reminder after one week, second reminder after two weeks). At the end of this survey, patients will be debriefed about the aim of examining how information about the environmental impact of surgery affects treatment choice.

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: Intervention conditionExperimental treatment 1 intervention
Group B: Control conditionNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Treatment preference (surgery or wait-and-see)

The primary outcome is treatment preference. Specifically, participants will indicate their treatment preference by selecting either the option 'Surgery' or 'Wait and see' (dichotomous variable)

Time frame
baseline, pre-intervention

Secondary outcomes

1

Treatment certainty

Combination of treatment preference and certainty. Treatment certainty will be determined by answering the question 'How sure are you about what you want?' on a scale from 1 (Very uncertain) to 10 (Very certain). Treatment preference\*certainty will be calculated after data collection by multiplying treatment preference (coded as 1 for surgery and -1 for wait and see thus no surgery) with treatment certainty, resulting in a scale from -10 (Very certain about choosing no surgery) to +10 (Very certain about choosing surgery). Adding this continuous measure allows for capturing more nuanced differences between the intervention and control conditions compared to dichotomous measures.

Time frame
baseline, pre-intervention
2

Treatment decision

Secondary outcome is treatment decision (number of patients that choose surgery and number of patients that choose wait-and-see)

Time frame
Assessment 3 months after the participants receive the decision aid

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Amsterdam

Lead sponsor

Radboud University Medical Center

Collaborator

Leiden University Medical Center

Collaborator

This trial is not recruiting at the moment. You can still explore other options: